The WorldWide Antimalarial Resistance Network (WWARN), the founding platform for the broader Infectious Diseases Data Observatory, generates innovative tools and reliable evidence regarding factors affecting the efficacy of antimalarial medicines, including optimised treatment regimens for vulnerable groups such as pregnant women, infants and malnourished children. The Tools and Resources pages offer support for developing and gathering research evidence in a quality and harmonised way.​

The Global Health Network is collaborating with MARC-SE, a project focused on mitigating antimalarial resistance in South-East Africa funded by the Global Health EDCTP3 Joint Undertaking. The Global Health Network contributes to Work Package 2 (Addressing Key Evidence Gap)s by cataloguing tools to measure antimalarial efficacy and the impact of resistance, and mapping these onto the gaps identified in Work Package 1 (Network, Landscape and Gap Analysis). These activities will enhance the efficiency and quality of data collection and evidence production.

The MESA Alliance believes that in order to control and eliminate malaria, there is a need to sustain, as part of a global response, the scientific research effort behind engineering innovations to better combat the disease and manage its carriers, as well as strengthening human knowledge on optimizing intervention strategies on the ground. We work towards this mission by emphasizing and complementing the use and examination of evidence in different strategic contexts, to ensure that global policymaking and programme implementations on the ground are evidence-based and strengthened through new understanding. We are hosted by the Barcelona Institute for Global Health and support fulfilling its mandate as a WHO Collaborating Centre for Malaria Control, Elimination and Eradication. Find out more here.